Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma (Q72269085)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

main subject

localized scleroderma

1 reference

H Ihn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S Sato

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

M Fujimoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

K Kikuchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

K Takehara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

Archives of Dermatological Research

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

193-197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

Systemic scleroderma, A clinical study of 727 cases

25 October 2019

cites work

1 reference

12 December 2020

Antinuclear antibodies in the relatives of patients with systemic sclerosis

1 reference

12 December 2020

The cutaneous collagenoses

1 reference

12 December 2020

Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma

1 reference

12 December 2020

Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis

1 reference

12 December 2020

Enhanced production of interleukin-2 in patients with progressive systemic sclerosis. Hyperactivity of CD4-positive T cells?

1 reference

12 December 2020

Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations

1 reference

12 December 2020

Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil

1 reference

12 December 2020

Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils.

1 reference

12 December 2020

Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4

1 reference

12 December 2020

Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma

1 reference

12 December 2020

The biology of interleukin-6

1 reference

12 December 2020

Functional and morphologic characterization of human T cells continuously grown in vitro

1 reference

12 December 2020

Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

1 reference

12 December 2020

Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities

1 reference

12 December 2020

Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor α, and Interferon-γ Levels in Sera from Patients With Scleroderma

1 reference

12 December 2020

Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones

1 reference

12 December 2020

Proceedings: Serologic abnormalities and their significance in localized scleroderma

1 reference

12 December 2020

Juvenile linear scleroderma associated with serologic abnormalities

1 reference

12 December 2020

Antinuclear antibodies in localized scleroderma

1 reference

12 December 2020

Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)

1 reference

12 December 2020

Restricted production of interleukin 4 by activated human T cells

1 reference

12 December 2020

Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

1 reference

12 December 2020

Pathophysiologic aspects of lymphokines.

1 reference

12 December 2020

Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat

1 reference

12 December 2020

Soluble immunologic products in scleroderma sera

1 reference

12 December 2020

B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells

1 reference

12 December 2020

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

12 December 2020

Generalized morphea. I. Histology of the dermis and subcutaneous tissue

1 reference

12 December 2020

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

1 reference

12 December 2020

When is scleroderma not scleroderma? The differential diagnosis of progressive systemic sclerosis

1 reference

12 December 2020

Antihistone antibodies in patients with localized scleroderma

1 reference

12 December 2020

1 reference

12 December 2020

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

1 reference

12 December 2020

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

1 reference

12 December 2020

Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration

1 reference

12 December 2020

Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis

1 reference

12 December 2020

Clinical evaluation of scleroderma spectrum disorders using a points system

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01262331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7763091%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference